Navigation Links
Synteract Sponsoring and Presenting at Outsourcing in Clinical Trials Southeast Conference
Date:5/8/2012

SAN DIEGO and RALEIGH-DURHAM, N.C., May 8, 2012 /PRNewswire/ -- Synteract, Inc., a full-service contract research organization (CRO), will be a corporate sponsor and have two senior level directors from its Research Triangle Park office speak at the inaugural Outsourcing in Clinical Trials Southeast conference to be held at the Durham Marriott Convention Center, May 15-16, 2012. Barbara Conley, associate director of clinical operations, and Matt Anders, associate director of project management, will co-present at 10:30 a.m. EDT, Wed., May 16th, on how to identify viable investigative sites that contribute to the success of a company's clinical study.

(Logo: http://photos.prnewswire.com/prnh/20111108/MM02925LOGO

The conference series is nationally respected and attended by vendors and sponsors in the pharmaceutical and biotech industries. Conley and Ander's presentation will address one of the growing concerns within drug development; how to find and choose viable trial sites.

Topics will include: 

  • Identifying what makes a site feasible for your trial
  • Establishing whether a site has ongoing studies competing for the same patient population
  • Assessing whether the site meets the country's standard of care  
  • Forecasting whether the length of your trial is acceptable to investigational staff and patients
  • Evaluating the availability of specialized equipment and expertise
  • Analyzing the consistency of the investigator budget with the level of investigational site effort required

According to Synteract executives, with trial costs on the rise finding appropriate investigative sites is a key driver in efficient trial conduct.  With site selection a critical component in the overall drug development process, it is important for biopharma companies of all sizes to work with a CRO that can facilitate choosing viable trial sites.

"After nearly two decades of operations, we're known for having a unique understanding of emerging pharma and biotech, particularly on the West Coast, where we are headquartered," stated Stewart Bieler, chief operating officer. "We continue to enhance the breadth and depth of our Raleigh-based service offering in response to increasing East Coast-based client demand.  This allows us to continue to offer a level of individualized service from experienced clinical development professionals on each project."

Synteract will exhibit at booth #27. CEO Wendel Barr will be available to discuss the company's Shared Work-Shared Vision approach where every project and client receives collaborative, customized service that is tailored to their needs. To set up an appointment in advance, contact Michele Sacher, associate business development director, at 484.467.5937 or msacher@synteract.com

About Synteract (www.synteract.com)
Synteract is a full-service contract research organization with a successful 17-year track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development.  With its "Shared Work – Shared Vision" philosophy Synteract provides customized Phase I through IV services collaboratively and cost effectively to ensure on-time delivery of quality data so clients get to decision points faster. Headquartered in California, with offices in North Carolina and the Czech Republic, Synteract delivers trials internationally, offering expertise across multiple therapeutic areas including notable depth in oncology, CNS, cardiovascular, respiratory and ophthalmology. 

CONTACT:
Rachel Hutman
Clearpoint Agency, for Synteract
rachel@clearpointagency.com
+1-760-230-2424


'/>"/>
SOURCE Synteract, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Synteract and Rempex Partner in "Great Strides" Walk to Support Cystic Fibrosis Cure
2. Synteract Expands Executive Roles to Support Growth
3. Synteract Hosting CDISC Classes on Regulatory Data Standards, Feb. 21-24, in California
4. Former Synteract CEO Unveils Non-Profit Contract Research Organization, PHACT, to Help Eliminate Neglected Diseases in Developing Countries
5. Synteract Releases SynCapture Version 1.5 of Its Hybrid Electronic Data Capture (EDC) System
6. RxAlly Expands National Network With Addition Of Nineteen Community Pharmacy Organizations Representing Over 2,000 Pharmacies
7. Attorney Mark Lanier Presenting Keynote at National Mesh Litigation Conference
8. Parata Systems Announces Presenting Sponsorship of 2012 Independent Pharmacy Business Growth Conference
9. Genprex Presenting at 10th Annual BIO Investor Forum
10. AMD Alliance, Representing AMD Patient Organizations Globally, Encourages Health Care Providers to Stop Using Avastin for Off-Label Ocular Use
11. Investment in Oncology Drug Development Remains Strong as 133 Companies Initiate Late-Stage Clinical Trials Representing a 21% Increase
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... a startling report released today, National Safety Council research ... proven plan to eliminate prescription opioid overdoses. Prescription Nation ... tackling the worst drug crisis in recorded U.S. history, assigned a ... , New Mexico , Tennessee ... failing states, three – Michigan , ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology and specialty ... Bracket eCOA (SM) 6.0, at the 52 nd ... in Philadelphia , Pennsylvania.  A demonstration of ... its kind to fully integrate with RTSM, will be held ... a flexible platform for electronic clinical outcomes assessments that is ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. ... accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, ... and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their ... Award, an essay contest in which patients and their families pay tribute to a ... the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions ... initiated cultivation and processing operations at its production facility, and opened its first ... is the manufacturer of a complete system of proactive air and surface purification ...
Breaking Medicine News(10 mins):